CureVac NV Valuation
| 5CV Stock | EUR 3.83 0.09 2.30% |
At this time, the firm appears to be overvalued. CureVac NV shows a prevailing Real Value of €3.65 per share. The current price of the firm is €3.83. Our model approximates the value of CureVac NV from analyzing the firm fundamentals such as Profit Margin of (1.26) %, current valuation of 792.23 M, and Return On Equity of -0.19 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CureVac NV's price fluctuation is risky at this time. Calculation of the real value of CureVac NV is based on 3 months time horizon. Increasing CureVac NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CureVac stock is determined by what a typical buyer is willing to pay for full or partial control of CureVac NV. Since CureVac NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CureVac Stock. However, CureVac NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.83 | Real 3.65 | Hype 3.83 | Naive 3.59 |
The real value of CureVac Stock, also known as its intrinsic value, is the underlying worth of CureVac NV Company, which is reflected in its stock price. It is based on CureVac NV's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CureVac NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CureVac NV helps investors to forecast how CureVac stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CureVac NV more accurately as focusing exclusively on CureVac NV's fundamentals will not take into account other important factors: CureVac NV Total Value Analysis
CureVac NV is presently estimated to have takeover price of 792.23 M with market capitalization of 1.85 B, debt of 55.28 M, and cash on hands of 1.33 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CureVac NV fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
792.23 M | 1.85 B | 55.28 M | 1.33 B |
CureVac NV Investor Information
About 46.0% of the company shares are owned by insiders or employees . The book value of CureVac NV was presently reported as 3.29. The company recorded a loss per share of 0.63. CureVac NV had not issued any dividends in recent years. Based on the key indicators related to CureVac NV's liquidity, profitability, solvency, and operating efficiency, CureVac NV is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.CureVac NV Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CureVac NV has an asset utilization ratio of 8.89 percent. This implies that the Company is making €0.0889 for each dollar of assets. An increasing asset utilization means that CureVac NV is more efficient with each dollar of assets it utilizes for everyday operations.CureVac NV Ownership Allocation
CureVac NV holds a total of 221.98 Million outstanding shares. CureVac NV retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CureVac NV Profitability Analysis
The company reported the revenue of 102.99 M. Net Loss for the year was (411.72 M) with loss before overhead, payroll, taxes, and interest of (135.09 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CureVac NV's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CureVac NV and how it compares across the competition.
About CureVac NV Valuation
The stock valuation mechanism determines CureVac NV's current worth on a weekly basis. Our valuation model uses a comparative analysis of CureVac NV. We calculate exposure to CureVac NV's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CureVac NV's related companies.CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. CUREVAC N operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 455 people.
8 Steps to conduct CureVac NV's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CureVac NV's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CureVac NV's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CureVac NV's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CureVac NV's revenue streams: Identify CureVac NV's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CureVac NV's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CureVac NV's growth potential: Evaluate CureVac NV's management, business model, and growth potential.
- Determine CureVac NV's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CureVac NV's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |